PRNewsWire
20 Nov 2025, 15:00 UTC · 48w ago
Verdict
Headline takes no side. We score ZBH −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Zimmer Biomet lowered the top end of its full-year organic revenue growth outlook to 3.5%–4% from a previous range of 3.5%–4.5%.
So whatA reduction in forward guidance typically leads to a downward revision of valuation models and indicates slowing growth momentum.
More negative than 95% of claims this week
Pomerantz LLP has launched an investigation into possible securities fraud and unlawful business practices by Zimmer Biomet and its officers.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 91% of claims this week
Zimmer Biomet reported Q3 2025 net sales of $2 billion, missing the consensus analyst estimate of $2.01 billion.
More negative than 85% of claims this week
The company cited weakness in international markets, specifically order cancellations in the Middle East and Eastern Europe, and lower-than-expected U.S. knee and hip replacement sales.
More negative than 77% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud investigation, missed sales estimates, lowered revenue outlook, and a significant stock price drop.
More negative than 86% of ticker scores this week
The company is the subject of an investigation into claims on behalf of investors by a law firm.
More negative than 86% of ticker scores this week
The company is the subject of an investigation into claims on behalf of investors by a law firm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
1h ago
+10.5%
Price is moving against the score
$98.81 vs $89.45 close before publication (Nov 19) · not market-adjusted
ZBH chart →
